Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 527

1.

Anxiety disorders: a comprehensive review of pharmacotherapies.

Hoffman EJ, Mathew SJ.

Mt Sinai J Med. 2008 May-Jun;75(3):248-62. doi: 10.1002/msj.20041. Review.

PMID:
18704983
2.

SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

Asnis GM, Kohn SR, Henderson M, Brown NL.

Drugs. 2004;64(4):383-404. Review.

PMID:
14969574
3.

The pharmacologic treatment of anxiety disorders: a review of progress.

Ravindran LN, Stein MB.

J Clin Psychiatry. 2010 Jul;71(7):839-54. doi: 10.4088/JCP.10r06218blu. Review.

PMID:
20667290
4.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
5.

Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety.

Kent JM, Coplan JD, Gorman JM.

Biol Psychiatry. 1998 Nov 1;44(9):812-24. Review.

PMID:
9807637
6.

Overview of diagnosis and drug treatments of anxiety disorders.

Nutt DJ.

CNS Spectr. 2005 Jan;10(1):49-56. Review.

PMID:
15618947
7.

The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.

Hedges DW, Brown BL, Shwalb DA, Godfrey K, Larcher AM.

J Psychopharmacol. 2007 Jan;21(1):102-11.

PMID:
16714326
8.

Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors.

Kasper S, Resinger E.

Eur Neuropsychopharmacol. 2001 Aug;11(4):307-21. Review.

PMID:
11532386
9.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Review. French.

PMID:
18922243
10.

Venlafaxine in the treatment of anxiety disorders.

Katzman M.

Expert Rev Neurother. 2004 May;4(3):371-81. Review.

PMID:
15853535
11.

[Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].

Ammar G, Naja WJ, Pelissolo A.

Encephale. 2015 Jun;41(3):260-5. doi: 10.1016/j.encep.2013.11.002. Review. French.

PMID:
25439852
12.

Pharmacotherapy for post-traumatic stress disorder: a comprehensive review.

Davis LL, English BA, Ambrose SM, Petty F.

Expert Opin Pharmacother. 2001 Oct;2(10):1583-95. Review.

PMID:
11825301
13.

Selective serotonin reuptake inhibitors in post-traumatic stress disorder.

Hidalgo RB, Davidson JR.

J Psychopharmacol. 2000 Mar;14(1):70-6. Review.

PMID:
10757257
14.

Selecting pharmacotherapy for generalized anxiety disorder.

Goodman WK.

J Clin Psychiatry. 2004;65 Suppl 13:8-13. Review.

15.

Pharmacotherapy of post-traumatic stress disorder.

Ravindran LN, Stein MB.

Curr Top Behav Neurosci. 2010;2:505-25. Review.

PMID:
21309124
16.

SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.

Gorman JM, Kent JM.

J Clin Psychiatry. 1999;60 Suppl 4:33-8; discussion 39. Review.

17.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.

Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ; WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disoders., Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lépine JP, Liebowitz MR, Lopez-Ibor JJ, Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, Sato M, Starcevic V, Stein DJ, van Ameringen M, Vega J.

World J Biol Psychiatry. 2008;9(4):248-312. doi: 10.1080/15622970802465807.

PMID:
18949648
18.

Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders.

Keck PE Jr, Strawn JR, McElroy SL.

J Clin Psychiatry. 2006;67 Suppl 1:8-15. Review.

19.

Panic: course, complications and treatment of panic disorder.

Pollack MH, Marzol PC.

J Psychopharmacol. 2000;14(2 Suppl 1):S25-30. Review.

PMID:
10888028
20.

[Biological basis of anxiety disorders and serotonergic anxiolytics].

Inoue T, Izumi T, Li XB, Huang JZ, Kitaichi Y, Nakagawa S, Koyama T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2004 Jun;24(3):125-31. Review. Japanese.

PMID:
15291241
Items per page

Supplemental Content

Support Center